A platelet transcriptomic signature of thromboinflammation predicts cardiovascular risk.

JCI Insight · 2025 · PMC12890503 · PMID 41424389

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Moreover, the highly significant decrease of TIPS in patients with baseline TIPS above the median supports the potential benefit of ticagrelor specifically in patients with elevated thromboinflammation.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.